Perrigo Company plc Income (Loss) from Continuing Operations before Income Taxes, Domestic
Perrigo Company plc (PRGO) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$620.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-26
- Perrigo Company plc income (loss) from continuing operations before income taxes, domestic for the quarter ending 2024-06-29 was -$74.00M, a 428.89% decline year-over-year.
- Perrigo Company plc income (loss) from continuing operations before income taxes, domestic for the quarter ending 2024-03-30 was -$98.60M, a 2393.02% decline year-over-year.
- Perrigo Company plc income (loss) from continuing operations before income taxes, domestic for the quarter ending 2023-12-31 was $26.30M.
- Perrigo Company plc income (loss) from continuing operations before income taxes, domestic for the quarter ending 2023-09-30 was $19.20M.
- Perrigo Company plc income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$620.10M.
- Perrigo Company plc income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$224.10M, a 409.96% decline from fiscal 2023.
- Perrigo Company plc income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $72.30M.
- Perrigo Company plc income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$212.80M, a 162.24% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$620.10M 10-K · filed 2026-02-26 | |||||||
| 2024-12-31 | -$224.10M 10-K · filed 2026-02-26 | |||||||
| 2024-06-29 | -$74.00M 10-Q · filed 2024-08-02 | -$172.60M 10-Q · filed 2024-08-02 | -$146.30M derived: sum of 3 quarters · filed 2026-02-26 | -$127.10M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-30 | -$98.60M 10-Q · filed 2024-05-07 | -$72.30M derived: sum of 2 quarters · filed 2026-02-26 | -$53.10M derived: sum of 3 quarters · filed 2026-02-26 | -$30.60M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $26.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $45.50M derived: sum of 2 quarters · filed 2026-02-26 | $68.00M derived: sum of 3 quarters · filed 2026-02-26 | $72.30M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $19.20M 10-Q · filed 2023-11-07 | $41.70M derived: sum of 2 quarters · filed 2024-08-02 | $46.00M 10-Q · filed 2023-11-07 | -$42.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-07-01 | $22.50M 10-Q · filed 2024-08-02 | $26.80M 10-Q · filed 2024-08-02 | -$61.20M derived: sum of 3 quarters · filed 2025-02-28 | -$64.70M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-04-01 | $4.30M 10-Q · filed 2024-05-07 | -$83.70M derived: sum of 2 quarters · filed 2025-02-28 | -$87.20M derived: sum of 3 quarters · filed 2025-02-28 | -$195.50M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | -$88.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$91.50M derived: sum of 2 quarters · filed 2025-02-28 | -$199.80M derived: sum of 3 quarters · filed 2025-02-28 | -$212.80M 10-K · filed 2025-02-28 | ||||
| 2022-10-01 | -$3.50M 10-Q · filed 2023-11-07 | -$111.80M derived: sum of 2 quarters · filed 2023-11-07 | -$124.80M 10-Q · filed 2023-11-07 | -$31.70M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-07-02 | -$108.30M 10-Q · filed 2023-08-08 | -$121.30M 10-Q · filed 2023-08-08 | -$28.20M derived: sum of 3 quarters · filed 2024-02-27 | $360.70M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-04-02 | -$13.00M 10-Q · filed 2023-05-09 | $80.10M derived: sum of 2 quarters · filed 2024-02-27 | $469.00M derived: sum of 3 quarters · filed 2024-02-27 | $311.90M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $93.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $482.00M derived: sum of 2 quarters · filed 2024-02-27 | $324.90M derived: sum of 3 quarters · filed 2024-02-27 | $341.90M 10-K · filed 2024-02-27 | ||||
| 2021-10-02 | $388.90M 10-Q · filed 2022-11-08 | $231.80M derived: sum of 2 quarters · filed 2022-11-08 | $248.80M 10-Q · filed 2022-11-08 | -$52.40M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-07-03 | -$157.10M 10-Q · filed 2022-08-09 | -$140.10M 10-Q · filed 2022-08-09 | -$441.30M derived: sum of 3 quarters · filed 2023-02-28 | -$392.90M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-04-03 | $17.00M 10-Q · filed 2022-05-11 | -$284.20M derived: sum of 2 quarters · filed 2023-02-28 | -$235.80M derived: sum of 3 quarters · filed 2023-02-28 | -$220.30M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$301.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$252.80M derived: sum of 2 quarters · filed 2023-02-28 | -$237.30M derived: sum of 3 quarters · filed 2023-02-28 | -$179.90M 10-K · filed 2023-02-28 | -$411.80M 10-K · filed 2021-03-01 | |||
| 2020-09-26 | $48.40M 10-Q · filed 2021-11-12 | -$127.70M 10-Q · filed 2020-11-05 | $63.90M derived: sum of 2 quarters · filed 2021-11-12 | $121.30M 10-Q · filed 2021-11-12 | $58.80M 10-Q · filed 2020-11-05 | -$287.90M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-27 | $15.50M 10-Q · filed 2021-08-11 | $71.80M 10-Q · filed 2020-08-05 | $72.90M 10-Q · filed 2021-08-11 | $186.50M 10-Q · filed 2020-08-05 | -$336.30M derived: sum of 3 quarters · filed 2022-03-01 | -$239.00M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-28 | $57.40M 10-Q · filed 2021-05-12 | $114.70M 10-Q · filed 2020-05-05 | -$351.80M derived: sum of 2 quarters · filed 2022-03-01 | -$254.50M derived: sum of 3 quarters · filed 2022-03-01 | -$227.50M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$409.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$311.90M derived: sum of 2 quarters · filed 2022-03-01 | -$284.90M derived: sum of 3 quarters · filed 2022-03-01 | -$204.00M 10-K · filed 2022-03-01 | -$300.30M 10-K · filed 2020-02-27 | |||
| 2019-09-28 | $97.30M 10-Q · filed 2020-11-05 | $124.30M derived: sum of 2 quarters · filed 2020-11-05 | $205.20M 10-Q · filed 2020-11-05 | $9.30M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-29 | $27.00M 10-Q · filed 2020-08-05 | $107.90M 10-Q · filed 2020-08-05 | -$88.00M derived: sum of 3 quarters · filed 2021-03-01 | -$167.00M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-30 | $80.90M 10-Q · filed 2020-05-05 | -$115.00M derived: sum of 2 quarters · filed 2021-03-01 | -$194.00M derived: sum of 3 quarters · filed 2021-03-01 | -$138.70M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | -$195.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$274.90M derived: sum of 2 quarters · filed 2021-03-01 | -$219.60M derived: sum of 3 quarters · filed 2021-03-01 | -$109.00M 10-K · filed 2021-03-01 | ||||
| 2018-09-29 | -$79.00M 10-Q · filed 2019-11-06 | -$23.70M derived: sum of 2 quarters · filed 2019-11-06 | $86.90M 10-Q · filed 2019-11-06 | -$515.40M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $55.30M 10-Q · filed 2019-08-08 | $165.80M 10-Q · filed 2019-08-08 | -$436.40M derived: sum of 3 quarters · filed 2020-02-27 | -$307.70M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $110.50M 10-Q · filed 2019-05-09 | -$491.70M derived: sum of 2 quarters · filed 2020-02-27 | -$363.00M derived: sum of 3 quarters · filed 2020-02-27 | -$439.30M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$602.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$473.50M derived: sum of 2 quarters · filed 2020-02-27 | -$549.80M derived: sum of 3 quarters · filed 2020-02-27 | -$454.00M 10-K · filed 2020-02-27 | $280.10M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $128.70M 10-Q · filed 2018-11-08 | $52.40M derived: sum of 2 quarters · filed 2018-11-08 | $148.20M 10-Q · filed 2018-11-08 | -$271.50M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-07-01 | -$76.30M 10-Q · filed 2018-08-09 | $19.60M 10-Q · filed 2018-08-09 | -$400.20M derived: sum of 3 quarters · filed 2019-02-27 | -$2.30B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-04-01 | $95.80M 10-Q · filed 2018-05-08 | -$323.90M derived: sum of 2 quarters · filed 2019-02-27 | -$2.23B derived: sum of 3 quarters · filed 2019-02-27 | -$3.04B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$419.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$2.32B derived: sum of 2 quarters · filed 2019-02-27 | -$3.13B derived: sum of 3 quarters · filed 2019-02-27 | -$3.62B 10-K · filed 2019-02-27 | -$4.85B 10-K · filed 2017-05-22 | |||
| 2016-10-01 | -$1.90B 10-Q · filed 2017-11-09 | -$1.57B 10-Q · filed 2016-11-10 | -$2.71B derived: sum of 2 quarters · filed 2017-11-09 | -$3.20B 10-Q · filed 2017-11-09 | -$1.78B 10-Q · filed 2016-11-10 | -$3.49B derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-07-02 | -$812.20M 10-Q · filed 2017-08-10 | $151.60M 10-Q · filed 2016-08-10 | -$1.30B 10-Q · filed 2017-08-10 | -$207.60M 10-Q · filed 2016-08-10 | -$1.59B derived: sum of 3 quarters · filed 2018-03-01 | -$1.29B derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-04-02 | -$490.10M 10-Q · filed 2017-05-30 | -$359.20M 10-Q · filed 2016-05-16 | -$776.00M derived: sum of 2 quarters · filed 2018-03-01 | -$481.20M derived: sum of 3 quarters · filed 2018-03-01 | -$420.70M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | -$285.90M derived: 10-K 6 month − 10-Q/A 3 month · filed 2018-03-01 | $8.90M 10-K · filed 2018-03-01 | -$23.20M 10-KT · filed 2016-02-25 | $69.40M derived: sum of 3 quarters · filed 2018-03-01 | $59.20M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-09-26 | $294.80M 10-Q/A · filed 2017-05-23 | $132.20M 10-Q · filed 2016-11-10 | $355.30M derived: sum of 2 quarters · filed 2017-05-23 | $345.00M 10-Q/A · filed 2017-05-23 | $186.90M 10-Q · filed 2016-11-10 | |||
| 2015-06-27 | $60.50M 10-Q/A · filed 2017-05-22 | $157.40M 10-Q · filed 2016-08-10 | $50.20M 10-Q/A · filed 2017-05-22 | $54.80M 10-Q · filed 2016-08-10 | $260.30M 10-K · filed 2018-03-01 | $248.00M 10-K · filed 2015-08-13 | ||
| 2015-03-28 | -$10.20M 10-Q/A · filed 2017-05-22 | -$102.70M 10-Q · filed 2016-05-16 | ||||||
| 2014-12-27 | $210.00M 10-K · filed 2018-03-01 | $193.30M 10-KT · filed 2016-02-25 | ||||||
| 2014-06-28 | $303.60M 10-K · filed 2017-05-22 | $272.60M 10-K · filed 2015-08-13 | ||||||
| 2013-06-29 | $607.70M 10-KT · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |